Clinical Trial

Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will assess how different oral formulations of ubrogepant move through the body in healthy adult participants under fasting and fed conditions.
Trial Details
NCT Number NCT07680686
Lead Sponsor AbbVie
Conditions Healthy Volunteer
Enrollment 52 participants
Start Date 2026-06-30
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-02